Atrial fibrillation (AF), the most prevalent sustained cardiac arrhythmia, often coexists with the related arrhythmia atrial flutter (AFL). Limitations in effectiveness and safety of current therapies make an understanding of the molecular mechanism underlying AF more urgent. Genome-wide association studies implicated a region of human chromosome 4q25 in familial AF and AFL, ≈150 kb distal to the Pitx2 homeobox gene, a developmental left-right asymmetry (LRA) gene. To investigate the significance of the 4q25 variants, we used mouse models to investigate Pitx2 in atrial arrhythmogenesis directly. When challenged by programmed stimulation, Pitx2 null+/− adult mice had atrial arrhythmias, including AFL and atrial tachycardia, indicating that Pitx2 haploinsufficiency predisposes to atrial arrhythmias. Microarray and in situ studies indicated that Pitx2 suppresses sinoatrial node (SAN)-specific gene expression, including Shox2, in the left atrium of embryos and young adults. In vivo ChIP and transfection experiments indicated that Pitx2 directly bound Shox2 in vivo, supporting the notion that Pitx2 directly inhibits the SAN-specific genetic program in left atrium. Our findings implicate Pitx2 and Pitx2-mediated LRA-signaling pathways in prevention of atrial arrhythmias., the most common adult arrhythmia, increases in prevalence with age, eventually afflicting 5% of the population over age 65 years and 10% of those over age 80 years. Moreover, patients with AF have a significantly increased risk of stroke, heart failure, and dementia (1-3). Electrical impulses critical for a normal heartbeat are initiated in the sinoatrial node (SAN) or pacemaker region. In AF, rapid and irregular atrial activity overrides normal SAN function, often resulting in irregular impulse conduction to the ventricles. In many cases, ectopic electrical activity originates in the pulmonary veins and may serve to trigger and maintain AF (1, 4). The related arrhythmia, atrial flutter (AFL), displays more regular and organized electrical activity than does AF (5). Significantly, current treatments for AF are suboptimal because of incomplete effectiveness and deleterious side effects. It also has been recognized that untreated AF results in pathologic remodeling that makes AF more likely to recur (6). Thus, it is critically important to uncover the genetic mechanisms underlying AF to aid in patient management and to develop more safe and effective therapies.The pituitary homeobox (Pitx) family of homeobox genes containing three genes, Pitx1, Pitx2, and Pitx3, is a subgroup within the larger Paired-related superfamily of homeobox genes (7,8). Pitx2 was identified as the gene mutated in Rieger syndrome I, a haploinsufficient disorder that includes ocular, tooth, and anterior body wall defects as primary characteristics (9). Importantly, the Pitx2 gene encodes three isoforms: Pitx2a, Pitx2b, and Pitx2c. The Pitx2c isoform plays a critical role as a late effector in left-right asymmetry (LRA), a fundamental component of organ morphogenesis in vertebrate...